2023. Phase 3 Trial Demonstrating High Efficacy, Favourable Safety, and Convenience of a Novel Calcipotriene and Betamethasone Dipropionate Cream. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s128. DOI:https://doi.org/10.25251/skin.7.supp.128.